Reply to: “Comment on ‘Anti-aging effects of ingenol mebutate for patients with actinic keratosis' and phenol-croton oil peelings” - 16/05/19
Doi : 10.1016/j.jaad.2019.01.064
Miri Kim, MD, PhD, Yujin Jung, MD, Jongsic Kim, MD, Seo-won Jeong, BS, Yu Ri Woo, MD, Hyun Jeong Park, MD, PhD ⁎ 
Department of Dermatology, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea
∗Reprint requests: Hyun Jeong Park, Department of Dermatology, St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 62 Yeouido-dong, Youngdeungpo-ku, Seoul, 150-713, Republic of KoreaDepartment of DermatologySt. Mary's HospitalCollege of MedicineThe Catholic University of Korea62 Yeouido-dong, Youngdeungpo-kuSeoul150-713Republic of Korea
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Conflict of interest: None disclosed. |
© 2019
Publié par Elsevier Masson SAS.
Vol 80 - N° 6
P. e187 - juin 2019 Retour au numéro
Article précédent
- Comment on “Anti-aging effects of ingenol mebutate for patients with actinic keratosis” and phenol-croton oil peelings
- Carlos Gustavo Wambier, Kachiu Cecilia Lee, Thomas Michael Bertolini, Peter P. Rullan, Flavio Luis Beltrame
- Comment on “Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study” and a case report of glucagon-like peptide-1 receptor agonist–induced bullous pemphigoid
- Zachary Schwager, Anar Mikailov, Adam D. Lipworth
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?